Elehear Alpha vs Otofonix Encore

The Elehear Alpha is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $299, it sits in the most affordable price tier for over-the-counter devices, though its overall performance ranks #44 of 65 OTC hearing aids tested. This behind-the-ear device presents a distinctive performance profile with notable strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.2/5—a strong result that's 2.28 points above the category average. Feedback handling is also excellent at 5.0/5, meaning users can expect stable performance without whistling issues. However, core speech understanding metrics fall below category norms: speech in quiet scores a mixed 2.1/5 (0.73 points below average), while speech in noise is low at 1.0/5 (0.48 points below average). Own-voice comfort is a significant limitation, scoring just 0.7/5—a low result that's 1.81 points below the category average. This suggests users may experience noticeable occlusion effects when speaking. The Elehear Alpha is best suited for budget-conscious consumers who prioritize music and media streaming over speech clarity in challenging environments. Those needing stronger speech performance should consider alternatives like the Elehear Beyond or Olive Union Air, which offer better sound scores at similar or lower price points. For users primarily streaming podcasts, audiobooks, or music who have modest speech amplification needs, the Alpha's excellent streaming quality and feedback stability may justify its trade-offs.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.